Local entrepreneur and investor Rodger Ford joined artificial-heart maker SynCardia Systems in 2005 and helped the Tucson-based company raise money to develop key components and reach profitability.
A “bionic man” showcased in a Smithsonian Channel documentary and exhibit was designed as an artificial human, though it lacks several working organs.
The Food and Drug Administration has removed an import alert on a Mexican grower whose cucumbers were contaminated with salmonella earlier this year.
WASHINGTON - The Food and Drug Administration says it has uncovered potential safety problems at 30 specialty pharmacies that were inspected in the wake of a recent outbreak of meningitis caused by contaminated drugs.
WASHINGTON — The federal government, facing a court-imposed deadline and fierce opposition from the tobacco industry, has decided to abandon its legal fight to require cigarette makers to place large, graphic labels on their products warning of the dangers of smoking.
The following editorial was published Thursday in the Washington Post:
Five Arizona doctors and nurse practitioners are among more than 350 practices nationwide that may have received a Canadian drug supplier's shipment of unapproved Botox that could be counterfeit or unsafe, federal drug regulators say.
WASHINGTON — The Food and Drug Administration has halted operations of the country’s largest organic peanut butter processor, cracking down on salmonella poisoning for the first time with a new enforcement authority the agency gained in a 2011 food safety law.
TRENTON, N.J. - Pharmaceutical industry heavyweights are teaming up to address a challenge that's long vexed drugmakers: how to improve the way experimental drugs are tested so they can get approved and reach patients faster.
The former president and CEO of Critical Path Institute, Raymond Woosley, led a meeting three years ago at the organization's offices.
TRENTON, N.J. - Fewer new prescription drugs will get approved in the U.S. this year than the 30 approved in 2011, a ratings agency forecasts, adding to the many stresses on the pharmaceutical industry.
WASHINGTON — The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS.
MicroMed Cardiovascular Inc., a Houston company with ownership and leadership based in Tucson, today announced it has received approval from the U.S. Food and Drug Administration to conduct a clinical trial study of an implanted heart-assist device.